中国科技公司在STAR市场上,在AI、半导体和生物医学的推动下,在2025年取得了强劲的成果。 Chinese tech firms on the STAR Market saw strong 2025 results, driven by AI, semiconductors, and biomedicine.

中国在与纳斯达克类似的以技术为重点的交易所《STAR市场》上的公司在2025年头九个月取得了丰硕成果,收入增长7.9%至1.11万亿元,净利润增长8.9%至49.27亿元,这受半导体、AI、生物医学和新能源增长的驱动。 Companies on China’s STAR Market, a tech-focused exchange akin to Nasdaq, posted strong results in the first nine months of 2025, with revenue rising 7.9% to 1.11 trillion yuan and net profit up 8.9% to 49.27 billion yuan, driven by growth in semiconductors, AI, biomedicine, and new energy. 超过70%的公司实现了收入增长,近60%的公司报告利润增加,研发支出达到119.75亿元(净利润的2.4倍),研发的中位强度为12.4%。 Over 70% of firms saw revenue growth, nearly 60% reported higher profits, and R&D spending reached 119.75 billion yuan—2.4 times net profit—with a median R&D intensity of 12.4%. 市场引入了改革,包括一个科技增长层和投资者试点方案,以支持无利可图的高增长技术公司,加强其在推进中国技术自力更生方面的作用。 The market introduced reforms including a sci-tech growth tier and investor pilot programs to support unprofitable high-growth tech firms, reinforcing its role in advancing China’s technological self-reliance.